Nutex Health Inc. (NUTX)
NASDAQ: NUTX · Real-Time Price · USD
114.32
+3.54 (3.20%)
Jul 18, 2025, 2:38 PM - Market open
Nutex Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| 624.28 | 479.95 | 247.65 | 219.29 | 331.53 | 274.03 | Upgrade | |
Revenue Growth (YoY) | 141.25% | 93.80% | 12.93% | -33.85% | 20.98% | 182.34% | Upgrade |
Cost of Revenue | 299.96 | 264.72 | 195.28 | 190.74 | 144.59 | 104.56 | Upgrade |
Gross Profit | 324.32 | 215.23 | 52.37 | 28.55 | 186.94 | 169.47 | Upgrade |
Selling, General & Admin | 59.93 | 58.56 | 36.07 | 20 | 5.46 | 10.4 | Upgrade |
Operating Expenses | 115.86 | 77.53 | 53.66 | 33.13 | 13.12 | 16.29 | Upgrade |
Operating Income | 208.46 | 137.71 | -1.29 | -4.58 | 173.82 | 153.17 | Upgrade |
Interest Expense | -21.61 | -19.93 | -16.32 | -12.49 | -6.2 | -6.43 | Upgrade |
Other Non Operating Income (Expenses) | -7.11 | -0.94 | -0.4 | -0.56 | -0.12 | -1 | Upgrade |
EBT Excluding Unusual Items | 179.75 | 116.83 | -18.01 | -17.63 | 167.5 | 145.74 | Upgrade |
Merger & Restructuring Charges | -3.89 | -3.89 | -29.34 | -3.89 | -3.55 | - | Upgrade |
Impairment of Goodwill | -3.2 | -3.2 | -1.14 | -398.14 | - | - | Upgrade |
Other Unusual Items | - | - | - | - | 5.55 | - | Upgrade |
Pretax Income | 172.66 | 109.75 | -48.49 | -419.65 | 169.49 | 145.74 | Upgrade |
Income Tax Expense | 32.63 | 14.48 | -5.07 | 13.09 | 0.97 | 0.18 | Upgrade |
Earnings From Continuing Operations | 140.04 | 95.27 | -43.42 | -432.74 | 168.53 | 145.56 | Upgrade |
Minority Interest in Earnings | -72.86 | -43.09 | -2.36 | 7.96 | -35.93 | -39.59 | Upgrade |
Net Income | 67.18 | 52.18 | -45.79 | -424.78 | 132.59 | 105.97 | Upgrade |
Net Income to Common | 67.18 | 52.18 | -45.79 | -424.78 | 132.59 | 105.97 | Upgrade |
Net Income Growth | - | - | - | - | 25.12% | 406.47% | Upgrade |
Shares Outstanding (Basic) | 5 | 5 | 4 | 4 | 4 | 4 | Upgrade |
Shares Outstanding (Diluted) | 6 | 5 | 4 | 4 | 4 | 4 | Upgrade |
Shares Change (YoY) | 24.00% | 21.89% | 4.15% | 7.10% | - | - | Upgrade |
EPS (Basic) | 12.78 | 10.25 | -10.39 | -100.36 | 33.55 | 26.81 | Upgrade |
EPS (Diluted) | 12.01 | 9.71 | -10.39 | -100.36 | 33.00 | 26.81 | Upgrade |
EPS Growth | - | - | - | - | 23.07% | - | Upgrade |
Free Cash Flow | 69.43 | 20.85 | -8.24 | 35.97 | 136.51 | 25.48 | Upgrade |
Free Cash Flow Per Share | 12.35 | 3.88 | -1.87 | 8.50 | 34.54 | 6.45 | Upgrade |
Gross Margin | 51.95% | 44.84% | 21.14% | 13.02% | 56.39% | 61.84% | Upgrade |
Operating Margin | 33.39% | 28.69% | -0.52% | -2.09% | 52.43% | 55.90% | Upgrade |
Profit Margin | 10.76% | 10.87% | -18.49% | -193.70% | 39.99% | 38.67% | Upgrade |
Free Cash Flow Margin | 11.12% | 4.34% | -3.33% | 16.41% | 41.17% | 9.30% | Upgrade |
EBITDA | 227.28 | 156.68 | 16.3 | 8.55 | 179.09 | 156.66 | Upgrade |
EBITDA Margin | 36.41% | 32.65% | 6.58% | 3.90% | 54.02% | 57.17% | Upgrade |
D&A For EBITDA | 18.81 | 18.97 | 17.59 | 13.13 | 5.27 | 3.48 | Upgrade |
EBIT | 208.46 | 137.71 | -1.29 | -4.58 | 173.82 | 153.17 | Upgrade |
EBIT Margin | 33.39% | 28.69% | -0.52% | -2.09% | 52.43% | 55.90% | Upgrade |
Effective Tax Rate | 18.90% | 13.19% | - | - | 0.57% | 0.12% | Upgrade |
Revenue as Reported | 624.28 | 479.95 | 247.65 | 219.29 | 331.53 | 274.03 | Upgrade |
Updated May 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.